SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-18-001542
Filing Date
2018-03-01
Accepted
2018-03-01 16:26:34
Documents
2
Period of Report
2018-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s109214_8k.htm 8-K 23546
2 EXHIBIT 99.1 s109214_ex99-1.htm EX-99.1 140199
  Complete submission text file 0001615774-18-001542.txt   165071
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 18657739
SIC: 2834 Pharmaceutical Preparations